Résultats de la recherche - 7 results
Women’s perceptions and preferences toward HPV self-sampling in France: A questionnaire within the French CapU4 Trial
a conventional invitation letter). The trial invited 15,000 women aged 30–65, who had no screening test recorded since more than four years and who did not respond to an invitation letter within 12 months before. ...
Recovering radiotherapy services in England: Our plan for action
Abstract: In recent months, operational performance in radiotherapy has declined with services reporting long delays for patients needing treatment. However, this generally does not receive the same level of ...
Delayed treatment in breast cancer patients during the COVID-19 pandemic: a population health information research infrastructure (PHIRI) case study
the association of contextual factors with the observed changes in treatment delays. Results We observed empirical structural breakpoints on the monthly median time to surgery trend in Aragon (ranging ...
Improve the management of cancer-related cognitive impairment in clinical settings: a European Delphi study.
recommendations. Experts recommended the systematic screening of CRCI, followed by a short objective cognitive assessment, if complaints screened. A comprehensive evaluation is recommended if CRCI persists 6 months ...
Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.
classified with cervical intraepithelial neoplasia (CIN) grade 2+ (CIN2 +) (n = 102) or CIN3 + (n = 55) within the previous 18 months. Controls were women who had normal cytology results over two subsequent ...
Cytological screening for cervical cancer in the province of Limburg, Belgium.
screening interval was in the range of 12-14 months; the first quartile, median and third quartile were 355, 440 and 676 days, respectively. Over the 10 years, 82% of the target population had their Pap smear ...
Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008.
vaccinate 44% of all girls aged between 12-15 years. However, the trend was decreasing over the last 10 months. By the current reimbursement policy, we can expect that maximum half of the target population ...